How payers, PBMs, and formulary committees can convert LOE intelligence into measurable cost savings — and why most of them […]

A Practical Guide to Tracking Competitors’ R&D Pipelines Before They Make Headlines The Intelligence Gap That Costs Billions Every pharmaceutical

The Decision That Defines Decades of Revenue Somewhere between the FDA approval notice hitting a pharmaceutical company’s inbox and the

Patent Terms, Data Exclusivity, Compulsory Licensing, and Generic Entry Across 11 Markets Why South America Is the World’s Most Contested

A $28 Billion Opportunity Most Vendors Are Missing The 505(b)(2) pathway generates billions in annual drug revenue and runs on

Pharmaceutical executives routinely talk about patent cliffs as if they were acts of nature. They are not. The shape of

A strategic analysis for pharmaceutical companies, generic manufacturers, investors, and policy professionals The Indian Clock In most patent systems, the

Every major pharmaceutical patent war starts with a single form filed with the FDA. It is not a lawsuit. No

How litigation patterns, settlement timelines, and competitive pressure in biologics are rewriting the industry’s talent map — and what that